During the past decade, McGill University Department of Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 40 clinical trials were completed, i.e. on average, 444.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 16 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGill University Department of Oncology" #1 sponsor was "NCIC Clinical Trials Group" with 35 trials, followed by "National Cancer Institute (NCI)" with 20 trials sponsored, "Radiation Therapy Oncology Group" with 17 trials sponsored, "NRG Oncology" with 9 trials sponsored and "Canadian Cancer Trials Group" with 9 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGill University Department of Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Radiation Therapy Oncology Group" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator and "NRG Oncology" with 10 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "McGill University Department of Oncology" are "Breast Cancer" (11 trials), "Prostate Cancer" (10 trials), "Head and Neck Cancer" (5 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "McGill University Department of Oncology" in a lesser frequency.

Most popular intervention types in "McGill University Department of Oncology" are "Drug" (82 trials), "Radiation" (41 trials), "Other" (30 trials), "Biological" (17 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Quality-of-Life Assessment" (10 trials), "Cisplatin" (8 trials), "radiation therapy" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "McGill University Department of Oncology" are 68 trials for "All" genders, 25 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "McGill University Department of Oncology". undefined are not yet recruiting, 2 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in McGill University Department of Oncology, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in McGill University Department of Oncology, 10 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".